Calithera BioSciences

Calithera

This pharmaceutical company develops small-molecule drugs targeting cancer metabolism and tumour immunology for healthcare providers and patients with oncology and haematology conditions.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

Constellation Pharmaceuticals

This biopharmaceutical company develops small-molecule epigenetics therapies to treat patients with blood cancers and solid tumours.

Arcus Biosciences

This biopharmaceutical company develops molecules and combination therapies for patients with various forms of cancer and immune diseases.

1200 Pharma

This biotechnology firm develops small molecule therapies and drug intellectual property for the treatment of cancer patients.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Kymera Therapeutics

This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.

Frontier Medicines

This biopharmaceutical company develops small-molecule precision medicines targeting undruggable proteins for patients with cancer and immunological diseases.